Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Language
Publication year range
1.
Braz. J. Anesth. (Impr.) ; 72(6): 720-728, Nov.-Dec. 2022. tab, graf
Article in English | LILACS | ID: biblio-1420615

ABSTRACT

Abstract Background Hydroxyethyl starches are colloids used in fluid therapy that may reduce volume infusion compared with crystalloids, but they can affect renal function in critical care patients. This study aims to assess renal effects of starches using renal biomarkers in the perioperative setting. Methods This prospective, controlled, randomized study compared Hydroxyethyl starch 6% (HES) with Ringer's lactate (RL) in hysterectomy. Each episode of mean arterial pressure (MAP) below 60 mmHg guided the fluid replacement protocol. The RL group received 300 mL bolus of RL solution while the HES group received 150 mL of HES solution. All patients received RL (2 mL.kg−1.h−1) intraoperatively to replace insensible losses. Blood and urine samples were collected at three time points (preoperatively, 24 hours, and 40 days postoperatively) to assess urinary NGAL and KIM-1, as primary outcome, and other markers of renal function. Results Seventy patients were randomized and 60 completed the study. The RL group received a higher crystalloid volume (1,277 ± 812.7 mL vs. 630.4 ± 310.2 mL; p= 0.0002) with a higher fluid balance (780 ± 720 mL vs. 430 ± 440 mL; p= 0.03) and fluid overload (11.7% ± 10.4% vs. 7.0% ± 6.3%; p= 0.04) compared to the HES group. NGAL and KIM-1 did not differ between groups at each time point, however both biomarkers increased 24 hours postoperatively and returned to preoperative levels after 40 days in both groups. Conclusion HES did not increase renal biomarkers following open hysterectomy compared to RL. Moreover, HES provided better hemodynamic parameters using less volume, and reduced postoperative fluid balance and fluid overload.


Subject(s)
Hydroxyethyl Starch Derivatives , Fluid Therapy/methods , Biomarkers , Prospective Studies , Plasma Substitutes , Colloids , Lipocalin-2 , Crystalloid Solutions , Ringer's Lactate , Hysterectomy , Isotonic Solutions , Kidney/physiology
2.
Braz J Anesthesiol ; 72(6): 720-728, 2022.
Article in English | MEDLINE | ID: mdl-34848313

ABSTRACT

BACKGROUND: Hydroxyethyl starches are colloids used in fluid therapy that may reduce volume infusion compared with crystalloids, but they can affect renal function in critical care patients. This study aims to assess renal effects of starches using renal biomarkers in the perioperative setting. METHODS: This prospective, controlled, randomized study compared Hydroxyethyl starch 6% (HES) with Ringer's lactate (RL) in hysterectomy. Each episode of mean arterial pressure (MAP) below 60 mmHg guided the fluid replacement protocol. The RL group received 300 mL bolus of RL solution while the HES group received 150 mL of HES solution. All patients received RL (2 mL.kg-1.h-1) intraoperatively to replace insensible losses. Blood and urine samples were collected at three time points (preoperatively, 24 hours, and 40 days postoperatively) to assess urinary NGAL and KIM-1, as primary outcome, and other markers of renal function. RESULTS: Seventy patients were randomized and 60 completed the study. The RL group received a higher crystalloid volume (1,277 ± 812.7 mL vs. 630.4 ± 310.2 mL; p = 0.0002) with a higher fluid balance (780 ± 720 mL vs. 430 ± 440 mL; p = 0.03) and fluid overload (11.7% ± 10.4% vs. 7.0% ± 6.3%; p = 0.04) compared to the HES group. NGAL and KIM-1 did not differ between groups at each time point, however both biomarkers increased 24 hours postoperatively and returned to preoperative levels after 40 days in both groups. CONCLUSION: HES did not increase renal biomarkers following open hysterectomy compared to RL. Moreover, HES provided better hemodynamic parameters using less volume, and reduced postoperative fluid balance and fluid overload.


Subject(s)
Fluid Therapy , Hydroxyethyl Starch Derivatives , Female , Humans , Isotonic Solutions , Lipocalin-2 , Prospective Studies , Ringer's Lactate , Crystalloid Solutions , Fluid Therapy/methods , Colloids , Kidney/physiology , Hysterectomy , Biomarkers , Plasma Substitutes
3.
Acta cir. bras ; Acta cir. bras;30(6): 407-413, 06/2015. tab, graf
Article in English | LILACS | ID: lil-749649

ABSTRACT

PURPOSE: Vogt´s antioxidant solution (red blood cells, Ringer's solution, sodium bicarbonate, mannitol, allopurinol and 50% glucose) or its modification including hydroxyethyl starch (HES) were tested for the prevention of splanchnic artery occlusion shock. METHODS: Seventy rats were distributed in treatment (3), control (1), and sham (3) groups. Ischemia and reperfusion were induced by celiac, superior mesenteric and inferior mesenteric arteries occlusion for 40 min, followed by 60 min reperfusion or sham procedures. Controls received saline, both treatment and sham groups received the Vogt's solution, modified Vogt's solution (replacing Ringer's solution by HES), or HES. Mean arterial blood pressure (MABP), ileal malondialdehyde (MDA) and plasmatic MDA were determined, and a histologic grading system was used. RESULTS: At reperfusion, MABP dropped in all I/R groups. Only HES treatment was able to restore final MABP to the levels of sham groups. Plasmatic MDA did not show differences between groups. Ileum MDA was significantly higher in the control and treatment groups as compared to the sham group. Histology ranking was higher in the only in control group. CONCLUSIONS: Hydroxyethyl starch was able to prevent hemodynamic shock but not intestinal lesions. Both treatments with Vogt's solutions did not show any improvement. .


Subject(s)
Animals , Male , Hydroxyethyl Starch Derivatives/pharmacology , Mesenteric Arteries/drug effects , Mesenteric Vascular Occlusion/prevention & control , Plasma Substitutes/pharmacology , Reperfusion Injury/prevention & control , Disease Models, Animal , Hemodynamics/drug effects , Hydroxyethyl Starch Derivatives/therapeutic use , Ileum/blood supply , Ileum/pathology , Ischemia/prevention & control , Isotonic Solutions/pharmacology , Isotonic Solutions/therapeutic use , Malondialdehyde/analysis , Mesenteric Arteries/pathology , Mesenteric Vascular Occlusion/pathology , Plasma Substitutes/therapeutic use , Rats, Wistar , Reproducibility of Results , Splanchnic Circulation/drug effects , Time Factors , Treatment Outcome
4.
Acta cir. bras. ; 30(6): 407-413, June 2015. ilus, tab, graf
Article in English | VETINDEX | ID: vti-23132

ABSTRACT

PURPOSE: Vogt´s antioxidant solution (red blood cells, Ringer's solution, sodium bicarbonate, mannitol, allopurinol and 50% glucose) or its modification including hydroxyethyl starch (HES) were tested for the prevention of splanchnic artery occlusion shock.METHODS:Seventy rats were distributed in treatment (3), control (1), and sham (3) groups. Ischemia and reperfusion were induced by celiac, superior mesenteric and inferior mesenteric arteries occlusion for 40 min, followed by 60 min reperfusion or sham procedures. Controls received saline, both treatment and sham groups received the Vogt's solution, modified Vogt's solution (replacing Ringer's solution by HES), or HES. Mean arterial blood pressure (MABP), ileal malondialdehyde (MDA) and plasmatic MDA were determined, and a histologic grading system was used.RESULTS:At reperfusion, MABP dropped in all I/R groups. Only HES treatment was able to restore final MABP to the levels of sham groups. Plasmatic MDA did not show differences between groups. Ileum MDA was significantly higher in the control and treatment groups as compared to the sham group. Histology ranking was higher in the only in control group.CONCLUSIONS:Hydroxyethyl starch was able to prevent hemodynamic shock but not intestinal lesions. Both treatments with Vogt's solutions did not show any improvement.(AU)


Subject(s)
Animals , Rats , Antioxidants/therapeutic use , Hydroxyethyl Starch Derivatives/therapeutic use , Splanchnic Circulation , Shock/prevention & control , Reperfusion Injury/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL